Chemokines, in addition to their characterized functions as immune modulators, also play a role in developmental processes such as neural cell migration. Although, chemokines have been described in human, mouse and other vertebrate species, they have yet to be characterized in zebra®sh. In this paper, we report the isolation and expression analysis of scyba, a zebra®sh gene encoding a CXC-type chemokine protein.
Results and discussion
Chemokines comprise a family of secreted, structurallyrelated proteins, usually 8±10 kDa in molecular weight that have four conserved cystein residues. They have been classi®ed into four groups depending upon the number and spacing of the ®rst two conserved cystein residues C, CXC, CX3C, and CC. A large number of vertebrate chemokines and their receptors have been isolated (reviewed in Xia and Hyman, 1999) , however no chemokines have thus far been identi®ed in the zebra®sh (Danio rerio).
A cDNA clone whose sequence suggests that it encodes a chemokine was isolated in a subtraction screen for genes with zygotic expression. This clone contains an open reading frame encoding a peptide of 100 amino acids (Fig. 1A) . A sequence similarity search of the Genbank database using the deduced amino acid sequence from this cDNA identi®ed a large number of leukocyte chemo-attractant proteins. Four highly conserved cystein residues characteristic of the CXC family were correctly positioned within the zebra®sh peptide sequence, indicating that the gene isolated in this study may encode the ®rst zebra®sh member of the CXC protein family. The deduced zebra®sh peptide sequence showed the highest degree of identity with the human SCYB14 (previously named BRAK; 54% identity; 70% similarity) and mouse Scyb14 (52% identity, 67% similarity; Fig. 1B ). The next best matches also corresponded to chemokines, but the similarity was much lower (25% identity and 38% similarity with human SZ10; Fig. 1B ). Therefore, we have tentatively named this zebra®sh gene scyba because it clearly belongs to the Scyb family of chemokines but its orthology to mammalian Scyb14 genes is still tentative. We have mapped scyba, using the LN54 radiation hybrid panel (Hukriede et al., 1999) , to zebra®sh linkage group 14 at 0.00 cR from the microsatellite marker Z22128 (see http://z®sh.uoregon.edu/ZFIN for the zebra®sh radiation hybrid map).
Hydrophobicity analysis showed that the deduced Scyba peptide contains two hydrophobic regions, one of which is at the N-terminus, suggesting the presence of a signal peptide (Fig. 1C) . To test this possibility, we fused the open reading frame of Scyba to a N-terminal truncated alkaline phosphatase gene (AP) and transfected this construct into COS-7 cells. Cells transfected with the Scyba/AP fusion construct produced a 15-fold increase of AP enzy- (00)00408-1 www.elsevier.com/locate/modo matic activity in the medium compared to cells transfected with a control construct (AP alone; data not shown). This result con®rms that Scyba has a functional signal peptide at its N-terminus and that, at least in cultured cells, the Scyba protein can be secreted.
Northern analysis indicated that expression of scyba begins at around 12 hpf (data not shown). Using RNA in situ hybridization, scyba transcripts can ®rst be visualized at 12 hpf in the nascent otic placodes, the midbrain-hindbrain boundary (MHB) and presumptive epiphysial region of the diencephalon ( Fig. 2A,B) . Expression in the MHB extends more rostrally than that of pax 2.1 as determined by dual in situ hybridization (data not shown). However, expression of the two genes overlaps in the otic vesicle (see Riley et al., 1999 , for pax2.1 expression). At 25 hpf, scyba transcripts are no longer detectable in the midbrain regions, whereas expression persists in the cerebellum until 48 hpf (Fig. 2C) .
Expression of scyba in the otic placode is initially restricted to the anterior-and posterior-most compartments where the sensory maculae will form. The maculae are the ®rst of a series of sensory patches to develop within the otic vesicle and contain, as do all the future patches, specialized mechanotransducing hair cells that become innervated by the statoacoustic (VIIIth) nerve (see Haddon and Lewis, 1996 for review). As hair cells differentiate, a pseudostrati®ed epithelium is formed and scyba transcripts become con®ned to the upper hair-cell stratum (Fig. 2D) . Transcripts are also found in a region just outside the sensory patches, beginning at approximately 24 hpf and may correspond to the delaminating statoacoustic ganglion (asterisk in Fig.  2D ). By 48 hpf, cells in the newly developing cristae (Fig.  2E ) and of the developing head lateral line (Fig. 2F,G) express scyba. Hindbrain expression begins at 48 hpf in a series of discrete patches that likely correspond to a subset of commissural neurons (Fig. 2G,H) . By 3 dpf, scyba is no longer expressed in cells of the maculae, but continues in the hair-cell region of the three cristae (Fig. 2I) . By 4 days, scyba transcripts can also be found in the posterior lateral line (Fig. 2J) .
Studies have demonstrated that chemokines are active in non-hematopoietic cells of the central nervous system, with functions beyond the traditional leukocyte attraction Harrison et al., 1998; Ragozzino et al., 1998; Hesselgesser and Horuk, 1999; Lazarini et al., 2000) . However, none of the previously described chemokines are speci®cally expressed in the otic and lateral line sensory organs. The speci®c expression of scyba in the zebra®sh suggests that it may play a role in the development of the acoustico-lateralis system. The human SCYB14 (BRAK) is expressed ubiquitously in adult tissues but only rarely in cancer cell lines (Hromas et al., 1999) . Embryonic expression of mammalian Scyb14 genes has yet to be reported. Thus, the zebra®sh scyba differs from mammalian BRAK in that it is very speci®cally expressed, at least in embryos. Currently, we cannot rule out that scyba encodes a new type of CXC chemokine with no characterized human or mouse orthologue rather than the zebra®sh scyb14 ortholog.
Methods

cDNA cloning, sequencing and DNA constructs
The complete scyba cDNA was obtained by screening a 24-h zebra®sh cDNA library in lambda ZAP II using a radiolabeled probe corresponding to a partial cDNA fragment (approximately 500 bp) generated by subtraction between cDNAs from 19 and 2 hpf embryos. The scyba cDNA sequence is deposited in Genbank under accession number AF279919.
To generate Scyba-Aptag2 fusion construct, the open reading frame of scyba (without the stop codon) was ampli®ed by PCR and cloned into the APtag2 vector (Flanagan and Leder, 1990) . The primers used were: TACA-AGCTTGCGGGCTCTGCATATCAA, TACAGATCTG-GCTTCAAACGTCCTGTG.
Transfection and AP assay
COS-7 cells were cultured in DMEM medium. Plasmid DNA was linearized by digestion with Kpn I. Cells at 50% con¯uency were transfected with linearized DNA using the lipofectamin procedure (Gibco BRL). Transfected cells were then cultured in complete medium for 4 days. Alkaline phosphatase activity was determined in the culture medium as described (Flanagan and Leder, 1990) 2.3. Embryo staging, whole-mount RNA in situ hybridization and sectioning Zebra®sh embryos were obtained and staged according to standard procedures (Wester®eld, 1995) . Whole-mount in situ hybridization was performed as described previously (Akimenko et al., 1994) . The antisense scyba riboprobe corresponded to the entire 1.5 kb cDNA. Following in situ hybridization, 18 mm thick cryosections were made using standard techniques. 
